Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
VNX001 for Painful Bladder Syndrome
Recruiting1 awardPhase 2
Tucson, Arizona
This trial will enroll participants with bladder pain syndrome to test a new drug, VNX001, given through a catheter up to 6 times over 14 days for treating moderate to severe bladder pain
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service